Patient safety is the most important value for the Gedeon Richter Group. Thus monitoring adverse drug events occurring during pharmacotherapy is especially important for us. We offer to
Brak specjalnych zaleceń °C
According to the World Health Organisation, heart and circulatory diseases are the most common causes of deaths in developed countries, while arterial hypertension – which is an extremely dangerous and chronic disease – is the most common condition affecting the circulatory system.
Many women consider gynaecological issues – those involving...
Despite universal media access and numerous health-promoting preventive...
This section contains information intended solely for doctors, pharmacists and other persons authorised to receive specialty medical information.
If you are a doctor, pharmacist or are otherwise authorised to receive specialty medical information continue to the next page.
W przeciwnym razie, zapraszamy do zapoznania się z pozostałą częścią naszego serwisu powrót do strony głównej
We are all looking forward to new, excellent medicines and even more effective therapies. Sometimes, it takes a long time before the drug will be released to the market. It usually starts with the idea of a new product, a long period of research, testing, and the production and distribution of the new medicine.